Skip to main content
Premium Trial:

Request an Annual Quote

Stevenson Promoted to President of Applied Biosystems

NEW YORK (GenomeWeb News) – Mark Stevenson has been promoted to the position of president and chief operating officer of Applied Biosystems and senior vice president of Applera, ABI’s parent corporation.
Stevenson was promoted in July to executive vice president, after serving 15 months as president of the Molecular and Cellular Biology Division. Concurrent with that promotion, ABI had split the MCB Division into two groups: MCB Systems and MCB Consumables.
Before taking over at the helm of the MCB division, Stevenson had been president of ABI’s Applied Markets division. He has been with the firm since 1998 and has held several management positions with the company.
Stevenson’s appointment today “completes the Applied Biosystems management transition that began more than a year ago," said Tony White, chairman, president, and CEO of Applera, who has served as interim president of ABI since October 2006, when Cathy Burzik resigned.
“His experience in a variety of sales, marketing and general management roles in Europe, Japan, and the United States and his understanding of the market make him particularly qualified to manage all day-to-day operations at Applied Biosystems," said White.
Investment bank Morgan Stanley is in the midst of a review of Applera’s operations, which could potentially lead to a recommendation that ABI and sister company Celera trade as independent entities rather than as tracking stocks.


The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more